Skip to main content
Clinical Trials/NCT06115785
NCT06115785
Completed
N/A

Evaluation of the Effect of Cognitive Stimulation Therapy on Cognitive Status and Apathy in Olderly People With Mild Cognitive Impairment

Ejdane Coskun1 site in 1 country60 target enrollmentOctober 30, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mild Cognitive Impairment
Sponsor
Ejdane Coskun
Enrollment
60
Locations
1
Primary Endpoint
Standardized Mini Mental Test (SMMT)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study is to examine the effect of cognitive stimulation therapy on cognitive status and apathy in elderly individuals with mild cognitive impairment.

Detailed Description

This randomized controlled experimental study is planned for 30 October - 25 December 2023, with a total of 60 people (30 in the control group and 30 in the intervention group) at the Elderly Care and Rehabilitation Center. The data of the research were collected from the Literature-Based Personal Information Form, Standardized Mini Mental Test (SMMT), Apathy Assessment Scale. Approval from the Clinical Research Ethics Committee and written permission from the participants were obtained to conduct the study. Individuals in the intervention group started with introduction and in the first week, pre-test administration and CST will be administered twice for 45 minutes. For the next 7 weeks, it will be carried out for one week, with the introduction and pre-test application for individuals in the control group in the first week. They will continue their daily lives in two sessions for one week and two days. They will continue their lives in the following weeks. Written informed consent form will be given to all individuals in the study. It will start after information about the measurement tools is given.

Registry
clinicaltrials.gov
Start Date
October 30, 2023
End Date
December 25, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ejdane Coskun
Responsible Party
Sponsor Investigator
Principal Investigator

Ejdane Coskun

PhD, Lecturer

Osmaniye Korkut Ata University

Eligibility Criteria

Inclusion Criteria

  • Agree to participate in the study
  • Being literate and speaking Turkish fluently
  • Have communication and understanding skills
  • Standardized Mini Mental Test result being between 18-23 points
  • Having adequate vision and hearing functions for group participation

Exclusion Criteria

  • Presence of any sensory impairment
  • Having a physical health problem that may impair group cohesion and integrity

Outcomes

Primary Outcomes

Standardized Mini Mental Test (SMMT)

Time Frame: up to 9 weeks

This test consists of 11 items grouped into five subgroups measuring cognitive functions: orientation, recording memory, attention and calculation, recall and language. In SMMT, which is evaluated out of a total of 30 points, one point is given for each correct answer. Although scores of 23/24 for SMMT are considered the limit score for dementia; SMMT score between 18-23 points is considered as mild stage, 10-17 points as moderate stage, and 10 points or less as severe dementia.

Secondary Outcomes

  • Apathy Rating Scale (ARS)(up to 9 weeks)

Study Sites (1)

Loading locations...

Similar Trials